Company page

Fulcrum Therapeutics, Inc.

Fulcrum Therapeutics, Inc. (Ticker: FULC) is a public company based in the United States with a market capitalization of approximately $246.5 million. The company focuses on developing innovative therapies for patients with genetically defined diseases. Fulcrum is committed to advancing its research and development efforts to address unmet medical needs.